Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6026
IDT Corp
IDT
$1.64B
| $585K | ﹤0.01% |
22,618
+14,707
| +186% | +$454K |
|
6027
ProShares UltraShort QQQ
QID
$248M
| $585K | ﹤0.01% |
8,843
-1,334
| -13% | -$108K |
|
6028
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.41M
| $584K | ﹤0.01% |
12,554
+4,261
| +51% | +$199K |
|
6029
CALL
-1x Short VIX Futures ETF
SVIX
$166M
| $584K | ﹤0.01% |
20,800
-99,100
| -83% | -$2.08M |
|
6030
BlueLinx
BXC
$734M
| $584K | ﹤0.01% |
6,225
-660
| -10% | -$52.7K |
|
6031
ORIX
IX
$43.4B
| $583K | ﹤0.01% |
+31,965
| New | +$554K |
|
6032
PUT
Sempra
SRE
$55.1B
| $582K | ﹤0.01% |
8,000
-1,600
| -17% | -$120K |
|
6033
BlackRock Future Financial and Technology ETF
BPAY
$9.65M
| $582K | ﹤0.01% |
28,114
-6,346
| -18% | -$125K |
|
6034
CALL
Valmont Industries
VMI
$9.66B
| $582K | ﹤0.01% |
2,000
-200
| -9% | -$57.8K |
|
6035
Corebridge Financial
CRBG
$14.8B
| $581K | ﹤0.01% |
32,925
-33,333
| -50% | -$556K |
|
6036
Tidewater
TDW
$4.49B
| $581K | ﹤0.01% |
10,477
-150,093
| -93% | -$6.87M |
|
|
TSE
6037
DELISTED
Trinseo
TSE
| $581K | ﹤0.01% |
45,823
-18,042
| -28% | -$291K |
|
6038
PUT
IonQ
IONQ
$17.5B
| $580K | ﹤0.01% |
42,900
+3,100
| +8% | +$25.8K |
|
6039
PUT
Omega Healthcare
OHI
$14B
| $580K | ﹤0.01% |
18,900
-19,400
| -51% | -$560K |
|
6040
Sprott Nickel Miners ETF
NIKL
$57.5M
| $580K | ﹤0.01% |
+26,991
| New | +$578K |
|
6041
Cullinan Oncology
CGEM
$1.21B
| $580K | ﹤0.01% |
53,883
+32,196
| +148% | +$342K |
|
6042
Helix Energy Solutions
HLX
$1.5B
| $579K | ﹤0.01% |
78,518
+58,715
| +296% | +$417K |
|
6043
Coursera
COUR
$1.51B
| $579K | ﹤0.01% |
44,479
+15,077
| +51% | +$180K |
|
6044
StoneX
SNEX
$7.92B
| $579K | ﹤0.01% |
+35,286
| New | +$630K |
|
6045
PUT
Portillo's
PTLO
$332M
| $579K | ﹤0.01% |
25,700
-16,100
| -39% | -$336K |
|
|
AAMI
6046
Acadian Asset Management
AAMI
$3.3B
| $579K | ﹤0.01% |
27,637
+17,048
| +161% | +$380K |
|
6047
CALL
Murphy Oil
MUR
$5.08B
| $578K | ﹤0.01% |
15,100
-4,300
| -22% | -$159K |
|
6048
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$18.7M
| $578K | ﹤0.01% |
1,584
-56
| -3% | -$28.2K |
|
|
ARI
6049
Apollo Commercial Real Estate
ARI
$879M
| $578K | ﹤0.01% |
51,062
-50,017
| -49% | -$505K |
|
6050
PUT
Travere Therapeutics
TVTX
$5.78B
| $578K | ﹤0.01% |
+37,600
| New | +$684K |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.